苏拉克萨诊断有限公司获得了SEBI的批准, 首次公开募股涉及OFS, 最多1.92亿股权. Suraksha Diagnostic Ltd receives SEBI approval for an IPO involving an OFS of up to 1.92 crore equity shares.
总部位于加尔各答的Suraksha Diagnostic Ltd已获得SEBI的批准, 首次公开募股 (IPO) 涉及出售股权 (OFS) 达1.92亿股, 收益将全部用于出售股东. Suraksha Diagnostic Ltd, based in Kolkata, has received approval from SEBI for an initial public offering (IPO) involving an Offer-for-Sale (OFS) of up to 1.92 crore equity shares, with proceeds going entirely to selling shareholders. 该公司提供综合病理和放射服务,为印度几个邦的大约114万病人提供服务。 The company, which provides integrated pathology and radiology services, serves around 1.14 million patients across several Indian states. 这些股份将列入孟买证券交易所和国家证券交易所。 The shares will be listed on the Bombay Stock Exchange and National Stock Exchange.